GeneDx to Participate in 6th Annual Evercore ISI HealthCONx Conference
28 November 2023 - 10:05PM
GeneDx (Nasdaq: WGS), a leader in delivering improved health
outcomes through genomic and clinical insights, today announced
that company management will participate in the Evercore ISI
HealthCONx Conference this week in Miami, FL. Katherine Stueland,
President and Chief Executive Officer, will participate in a
fireside chat on Thursday, November 30, 2023, at 10:50 a.m. ET.
A live and archived webcast of the presentation
will be available on the “Events” section of the GeneDx investor
relations website at ir.genedx.com/news-events/events.
About GeneDxGeneDx (Nasdaq: WGS) delivers
personalized and actionable health insights to inform diagnosis,
direct treatment and improve drug discovery. The company is
uniquely positioned to accelerate the use of genomic and
large-scale clinical information to enable precision medicine as
the standard of care.
GeneDx is at the forefront of transforming
healthcare through its industry-leading exome and genome testing
and interpretation, fueled by one of the world’s largest, rare
disease data sets. For more information, please
visit www.genedx.com and connect with us
on LinkedIn, Facebook, Twitter and Instagram.
GeneDx Investor Relations Contact:
Investors@GeneDx.com
GeneDx Media Contact: Press@GeneDx.com
GeneDx (NASDAQ:WGS)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
GeneDx (NASDAQ:WGS)
Historical Stock Chart
Von Jun 2023 bis Jun 2024